Cargando…
Cytokines and subarachnoid hemorrhage
Subarachnoid hemorrhage (SAH) remains a potentially devastating cerebrovascular disease with a high morbidity and mortality rate, irrespective of treatment. The disease still has a 40–50% mortality rate with a 70% rate of cerebral vasospasm in those patients. The release of cytokines has been implic...
Autores principales: | Ruchika, FNU, Shah, Siddharth, Delawan, Maliya, Durga, Neupane, Lucke-Wold, Brandon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10657139/ https://www.ncbi.nlm.nih.gov/pubmed/37982005 http://dx.doi.org/10.59400/ivd.v1i1.55 |
Ejemplares similares
-
Understanding the Molecular Progression of Chronic Traumatic Encephalopathy in Traumatic Brain Injury, Aging and Neurodegenerative Disease
por: Ruchika, FNU, et al.
Publicado: (2023) -
Exploration of treatments for subarachnoid hemorrhage
por: Hosseini Siyanaki, Mohammad Reza, et al.
Publicado: (2022) -
Subarachnoid hemorrhage: management considerations for COVID-19
por: Panther, Eric J., et al.
Publicado: (2022) -
The glymphatic system and subarachnoid hemorrhage: disruption and recovery
por: Quintin, Stephan, et al.
Publicado: (2022) -
Neuroinflammation and subarachnoid hemorrhage: a revised look at the literature
por: Sriram, Sai, et al.
Publicado: (2022)